抗血小板药物及其引起的相关消化道损伤的临床研究进展  

Progress of clinical research on antiplatelet drugs and related gastroint estinal injury

作　　者：熊红[1] 邓园园 李静[2] 余云飞 XIONG Hong;DENG Yuanyuan;LI Jing;YU Yunfei(Department of Gastroenterology,924 Hospi tal of Joint Logistic Support Force,Guilin 541000;Department of Cardiology,924 Hospi tal of Joint Logistic Support Force,Guilin 541000)

机构地区：[1]中国人民解放军联勤保障部队第924医院消化内科,广西桂林541000 [2]中国人民解放军联勤保障部队第924医院心脏内科,广西桂林541000

出　　处：《当代医药论丛》2022年第15期33-35,共3页

基　　金：广西壮族自治区卫生健康委员会自筹经费课题(Z20201300)。

摘　　要：抗血小板治疗是防治心脑血管疾病的“重要基石”,但抗血小板药物会对上消化道造成一定程度的损伤。有研究指出,抗血小板治疗引起的消化道损伤是可防可治的。如何在提高抗血小板药物治疗效果的同时有效预防其引起的相关消化道损伤是目前临床上研究的热点。本文主要是对抗血小板药物及其引起的相关消化道损伤的临床研究进展进行综述。Antiplatelet therapy is the“important cornerstone”for the prevention and treatment of cardiovascular and cerebrovascular diseases,but antiplatelet drugs will cause certain degree of damage to the upper digestive tract.Some studies have pointed out that the digestive tract injury caused by antiplatelet therapy can be prevented and treated.How to effectively prevent gastrointestinal tract injury caused by antiplatelet drug therapy while improving its effect is a hot spot in clinical research.This article reviews the progress of clinical researc h on antiplatelet drugs and related gastrointestinal injury.

关 键 词：抗血小板药物 相关消化道损伤 研究进展 

分 类 号：R57[医药卫生—消化系统]